Principal Financial Group Inc Horizon Therapeutics Public LTD CO Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$98.98 - $115.74 $82,846 - $96,874	-837 Reduced 1.92%	42,829 $4.95 Million
Q2 2023 Aug 07, 2023	BUY	$96.34 - $112.38 $205,396 - $239,594	2,132 Added 5.13%	43,666 $4.49 Million
Q1 2023 May 09, 2023	SELL	$107.32 - $113.5 $85.9 Million - $90.8 Million	-800,406 Reduced 95.07%	41,534 $4.53 Million
Q4 2022 Feb 09, 2023	SELL	$62.39 - $113.8 $10.4 Million - $19 Million	-167,148 Reduced 16.56%	841,940 $95.8 Million
Q3 2022 Nov 09, 2022	SELL	$58.92 - $84.67 $14.9 Million - $21.4 Million	-253,174 Reduced 20.06%	1,009,088 $62.5 Million
Q2 2022 Aug 10, 2022	BUY	$79.4 - $116.36 $7.45 Million - $10.9 Million	93,807 Added 8.03%	1,262,262 $101 Million
Q1 2022 May 09, 2022	SELL	$86.42 - $109.81 $3.73 Million - $4.74 Million	-43,137 Reduced 3.56%	1,168,455 $123 Million
Q4 2021 Feb 09, 2022	SELL	$98.56 - $119.91 $6.82 Million - $8.3 Million	-69,247 Reduced 5.41%	1,211,592 $131 Million
Q3 2021 Nov 09, 2021	SELL	$91.91 - $110.37 $5.3 Million - $6.36 Million	-57,635 Reduced 4.31%	1,280,839 $140 Million
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $2.48 Million - $2.76 Million	-28,729 Reduced 2.1%	1,338,474 $125 Million
Q1 2021 May 10, 2021	BUY	$71.83 - $95.48 $57.2 Million - $76 Million	796,054 Added 139.38%	1,367,203 $126 Million
Q4 2020 Feb 08, 2021	BUY	$67.0 - $84.39 $2.01 Million - $2.53 Million	30,007 Added 5.55%	571,149 $41.8 Million
Q3 2020 Nov 06, 2020	SELL	$55.23 - $79.93 $5.57 Million - $8.06 Million	-100,790 Reduced 15.7%	541,142 $42 Million
Q2 2020 Aug 05, 2020	SELL	$30.2 - $56.98 $188,206 - $355,099	-6,232 Reduced 0.96%	641,932 $35.7 Million
Q1 2020 May 12, 2020	SELL	$24.87 - $38.56 $2.89 Million - $4.49 Million	-116,319 Reduced 15.22%	648,164 $19.2 Million
Q4 2019 Feb 05, 2020	SELL	$25.43 - $36.67 $687,296 - $991,080	-27,027 Reduced 3.41%	764,483 $27.7 Million
Q3 2019 Nov 13, 2019	SELL	$23.0 - $27.97 $363,101 - $441,562	-15,787 Reduced 1.96%	791,510 $21.6 Million
Q2 2019 Aug 12, 2019	BUY	$22.81 - $28.48 $18.4 Million - $23 Million	807,297 New	807,297 $19.4 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account